MSD
This role supports the development and delivery of Most Favored Nations (MFN) insights related to global market access, pricing, reimbursement, and policy. The successful candidate will synthesize primary and secondary research to generate actionable intelligence for strategic decision-making in a rapidly evolving pharmaceutical landscape.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
15% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Associate Director, Market Access Intelligence
Bristol Myers Squibb
Market Access Specialist
AstraZeneca
Director, Global Access, Value & Economics, Taiwan
Intuitive
Value & Access Analyst
Novartis
Global Insights Manager
Amgen
Associate Director, Global Value, Access, Pricing, and Reimbursement
BeOne Medicines